• OPEN AN ACCOUNT
Indian Indices
Sensex
71,924.68 -547.65
( -0.76%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3529756
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
36.03
2985.28
EPS(TTM)
Face Value()
Div & Yield %
7.4
2
2.01
 

sterlite technologies ltd
Indo Credit Capital reports standalone net profit of Rs 0.09 crore in the March 2026 quarter
May 27,2026
Net profit of Indo Credit Capital remain constant at Rs 0.09 crore in the quarter ended March 2026 and also during the previous quarter ended March 2025. Sales rose 8.33% to Rs 0.13 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.06 crore in the year ended March 2026 as against net loss of Rs 0.05 crore during the previous year ended March 2025. Sales remain constant at Rs 0.13 crore in the year ended March 2026 and also during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.130.12 8 0.130.13 0
OPM %69.2375.00 --69.23-38.46 -
PBDT0.090.09 0 0.06-0.05 LP
PBT0.090.09 0 0.06-0.05 LP
NP0.090.09 0 0.06-0.05 LP